The European Commission and its public and private partners continue to mobilise the funds needed to accelerate the research, production and worldwide deployment of a vaccine, treatments and diagnostic tools against the new coronavirus "accessible to all at an affordable cost".
The €9.5 billion in pledges made since the first pledging marathon on 4 May are encouraging (see EUROPE B12493A10), but not enough, Ms von der Leyen stressed in a video message on Thursday 28 May, announcing the...